Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Shares Outstanding (2016 - 2025)

Phibro Animal Health has reported Shares Outstanding over the past 13 years, most recently at $20.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $20.0 million for Q4 2025, down 50.72% from a year ago — trailing twelve months through Dec 2025 was $20.0 million (down 50.72% YoY), and the annual figure for FY2025 was $20.4 million, down 49.71%.
  • Shares Outstanding for Q4 2025 was $40.5 million at Phibro Animal Health, roughly flat from $40.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PAHC hit a ceiling of $40.5 million in Q4 2025 and a floor of $20.2 million in Q2 2025.
  • Median Shares Outstanding over the past 5 years was $40.5 million (2021), compared with a mean of $38.5 million.
  • Biggest five-year swings in Shares Outstanding: rose 0.12% in 2021 and later tumbled 50.72% in 2025.
  • Phibro Animal Health's Shares Outstanding stood at $40.5 million in 2021, then changed by 0.0% to $40.5 million in 2022, then changed by 0.0% to $40.5 million in 2023, then changed by 0.0% to $40.5 million in 2024, then tumbled by 50.72% to $20.0 million in 2025.
  • The last three reported values for Shares Outstanding were $20.0 million (Q4 2025), $40.5 million (Q3 2025), and $20.4 million (Q2 2025) per Business Quant data.